Gelteq GELS 深 沪
已收盘 08-07 16:00:00 美东时间
0.5579
-0.016
-2.80%
华盛通- 最 高0.5832
- 今 开0.5832
- 成交量 1.14万股
- 最 低 0.5459
- 昨 收 0.574
- 总市值 597.57万
- 52周最高 2.02
- 市盈率 静 --
- 换手率 0.11%
- 52周最低 0.387
- 委 比 26.21%
- 总股本 1071.11万
- 历史最高 5.50
- 量 比 0.21
- 振 幅 6.50%
- 历史最低 0.387
- 每 手 1
- 风险率 0.32%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多10 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Gelteq (NASDAQ:GELS) shares moved upwards by 50.5% to $1.49 during Monday's pre-market session. The company's market cap stands at $10.6 million. Quantum Cyber (NASDAQ:QUCY) shares moved upwards by 15.58% to $2.0. The market value of their outstanding shares is at $39.3 million. Cypherpunk T...
06-15 20:05
What's Going On With Gelteq Stock Friday?
Gelteq Limited (NASDAQ:GELS) stock is trading lower on Friday. The stock is experiencing a stark pullback following a period of extreme volatility. On Thursday, GELS shares skyrocketed by nearly 200%, making it a prime target for profit-taking. The downward price action on Friday reflects a classic ...
06-13 01:24
Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq® Technology for Animal Health Applications
Gelteq Limited successfully completed veterinary palatability trials with Kemin Industries, demonstrating its Gelteq® technology effectively masks bitter flavors and enhances palatability in animal health products. The trials validate the technology's potential for veterinary pharmaceutical applications and strengthen Gelteq's position in the animal health market. The outcomes support future partnerships and product development across pharmaceuti...
06-12 16:30
Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion
Gelteq Limited announced the establishment of a new Center of Excellence in Guangdong Province, China, to strengthen its global development platform and integrate into the rapidly growing pharmaceutical and biotechnology ecosystem. The center will accelerate product development, enhance formulation and testing capabilities, and support multiple projects simultaneously. This strategic move aligns with global industry trends and positions Gelteq to...
06-04 13:08
Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway
Gelteq Limited has initiated its first clinical trial for an antiparasitic drug candidate using Gelteq® technology, marking a milestone as the company expands into the veterinary pharmaceutical sector. The trial aims to support FDA regulatory approval for animal use, targeting a potential application in 2026. CEO Nathan Givoni emphasized the versatility of Gelteq® technology across human and animal health. The global animal health market is proje...
05-20 12:00
Gelteq Announces $3.5M Strategic Debt Financing To Expand Commercialization And Clinical Trial Activity
The debt financing will provide Gelteq USD $1 million on closing, with a further USD $2.5 million available to Gelteq upon receipt of shareholder approval for the financing, which the Company intends to seek in June
05-12 20:08
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Galmed Pharmaceuticals (NASDAQ:GLMD) stock increased by 83.2% to $1.14...
04-09 20:05
Gelteq and Healthy Extracts Sign MOU To Accelerate Gel-Based Product Rollouts
Healthy Extracts will serve as the primary manufacturer, commercial seller, and distribution partner for this range of products. Gelteq will provide the required technical transfer to enable manufacturing whilst
02-11 21:48
Gelteq and Healthy Extracts to Expand Gel-Based Nutrition Technologies with New Strategic Manufacturing & Commercial Partnership
Gelteq and Healthy Extracts have signed a strategic partnership to accelerate the commercial rollout of next-generation gel-based nutraceutical products. Gelteq will provide its proprietary gel delivery technology, while Healthy Extracts will leverage its U.S.-based manufacturing capabilities for production and global distribution. The collaboration aims to meet growing demand for innovative delivery formats in nutrition and expand into new marke...
02-11 13:45
What's Driving Gelteq Ltd.'s (GELS) Over 69% After-Hours Surge?
Shares of Gelteq Ltd. jumped 69.25% in after-hours trading following the company's announcement of encouraging preclinical data for its cannabinoid oral gel platform.
01-14 12:01
